AstraZeneca Covid vax found 79% effective in US trial
British-Swedish pharmaceutical major AstraZeneca on Monday said its vaccine demonstrated efficacy of 79 per cent at preventing symptomatic Covid-19 and 100 per cent efficacy at preventing severe disease and hospitalisation in a phase-3…